Pređi na sadržaj

SGE-301

Dodaj veze
S Vikipedije, slobodne enciklopedije
SGE-301
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-5-hidroksi-5-metilheksan-2-il]-3,10,13-trimetil-1,2,4,7,8,9,11,12,14,15,16,17-dodekahidrociklopenta[a]fenantren-3-ol
Nazivi
IUPAC naziv
(3S,8S,9S,10R,13R,14S,17R)-17-[(2R)-5-hidroksi-5-metilheksan-2-il]-3,10,13-trimetil-1,2,4,7,8,9,11,12,14,15,16,17-dodekahidrociklopenta[a]fenantren-3-ol
Drugi nazivi
  • SGE 301
  • 1427208-12-5
  • CHEMBL4448829
  • SCHEMBL16786261
  • BDBM50528615
Identifikacija
3D model (Jmol)
  • CC(CCC(C)(C)O)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)(C)O)C)C
Svojstva
C27H46O2
Molarna masa 402,66 g·mol−1
Ukoliko nije drugačije napomenuto, podaci se odnose na standardno stanje materijala (na 25 °C [77 °F], 100 kPa).
Reference infokutije

SGE-301 je agonist NMDA receptora.[3]

Reference

[uredi | uredi izvor]
  1. ^ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today. 15 (23-24): 1052—7. PMID 20970519. doi:10.1016/j.drudis.2010.10.003.  uredi
  2. ^ Evan E. Bolton; Yanli Wang; Paul A. Thiessen; Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry. 4: 217—241. doi:10.1016/S1574-1400(08)00012-1. 
  3. ^ D. E. Jane; H. W. Tse; D. A. Skifter; J. M. Christie; D. T. Monaghan. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Glutamate Receptor Ion Channels: Activators and Inhibitors. Pharmacology of Ionic Channel Function: Activators and Inhibitors. Springer. str. 415—478. 
Preuzeto iz „https://sr.wikipedia.org/w/index.php?title=SGE-301&oldid=28299315”